Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**2,4-Diamino–5–phenyl–6–ethylpyrimidine** is a synthetic small molecule belonging to the aminopyrimidine class of heterocyclic aromatic organic compounds. It has the molecular formula C12H14N4 and a molecular weight of approximately 214.27 g/mol[1][2][9]. The compound is structurally related to pyrimethamine but lacks the para-chloro substituent on the phenyl ring[5]. It has been studied as an experimental agent and is not approved for clinical use in any country[1][7]. Its mechanism of action includes inhibition of thymidylate synthase based on biochemical studies and structural data from ligand-protein complexes[7]. No approved indications or marketed formulations are known.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2,4-diamino-5-phenyl-6-ethylpyrimidine.